These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
605 related articles for article (PubMed ID: 23691561)
1. [Clinical significance of new classification of gastroenteropancreatic neuroendocrine neoplasms]. Zhu XZ Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):12-4. PubMed ID: 23691561 [TBL] [Abstract][Full Text] [Related]
2. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Klöppel G Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification. Anlauf M Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474 [TBL] [Abstract][Full Text] [Related]
4. Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study. Kai K; Nasu K; Nishida H; Daa T; Shikama A; Shiozaki T; Kurakazu M; Yano M; Imamura Y; Tokunaga H; Tasaki K; Iida Y; Yamada Y; Morisawa H; Nakagawa S; Fujimoto E; Tsuruta T; Matsumoto H; Arakawa A; Nonaka M; Takano H; Ushiwaka T; Mori T; Ito K; Motohashi T; Teramoto N; Yamada T Neuroendocrinology; 2021; 111(4):320-329. PubMed ID: 32097950 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208 [TBL] [Abstract][Full Text] [Related]
6. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon. Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650 [TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737 [TBL] [Abstract][Full Text] [Related]
8. Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms. Kidd M; Modlin I; Öberg K Nat Rev Clin Oncol; 2016 Nov; 13(11):691-705. PubMed ID: 27273044 [TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches. Oberg K Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940 [TBL] [Abstract][Full Text] [Related]
10. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract. Rindi G; Capella C; Solcia E Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598 [TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification]. Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261 [TBL] [Abstract][Full Text] [Related]
12. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors. Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616 [TBL] [Abstract][Full Text] [Related]
13. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center. Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205 [TBL] [Abstract][Full Text] [Related]
15. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms]. Tan H Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986 [TBL] [Abstract][Full Text] [Related]
16. Prognoses in patients with primary gastrointestinal neuroendocrine neoplasms based on the proposed new classification scheme. Yin XN; Shen CY; Yin YQ; Chen HJ; Chen HN; Yin Y; Han LY; Chen JJ; Tang SM; Chen ZX; Zhang B Asia Pac J Clin Oncol; 2018 Apr; 14(2):e37-e44. PubMed ID: 28856815 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications. Fazio N; Milione M Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009 [TBL] [Abstract][Full Text] [Related]
19. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)]. Klöppel G Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346 [TBL] [Abstract][Full Text] [Related]
20. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria. Martin JA; Warner RR; Wisnivesky JP; Kim MK Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]